COVID-19(6) ACE2(5) AT1 receptor blocker(4) Biomarker(4) CRP(4) ATIR(4) renin-angiotensin system(4) IL-1(4) antihypertensive drugs(4) supplementary material(4) blocker(4) severity(4) determine(4) hACE2(4) inflammation marker(4) receptor(4) COVID-19 patient(4) acute respiratory syndrome(4) hypertensive(4) SARS-CoV-2(4) required(4) IL-6(4) outcome(4) hypertensive COVID-19 patient(4) serum(4) hospitalized COVID-19 patient(4) Inpatient(4) higher risk(4) Effect(4) coronavirus(4)